SLC38A7 and cancer: Rodriguez PC et al. showed that, during tumor progression, cancer cells increase expression of amino acids transporters, reducing amino acids in the TME, hindering expansion, differentiation, and function in tumor-infiltrating lymphocytes (TILs) [20].